EtherMed 🏥

AI operating system for healthcare approvals.

March 18, 2026

Spotlight

What if approvals never delayed care because no one had to process them at all?

Quick Pitch: EtherMed is building an AI prior authorization platform that runs end to end inside existing systems, removing manual work for providers and payors with no new tools or retraining.

The Problem

  • Administrative Overload: A single prior authorization can require more than 10 touches and up to 5.5 hours, consuming clinical time.

  • Systemic Delays: Most physicians report care delays tied to prior authorization, with many cases leading to serious health risks or treatment abandonment.

  • Scale Mismatch: Hundreds of millions of authorizations are processed each year, yet most still rely on fax and phone with no unified infrastructure.

Snapshot

  • Industry: Healthcare AI and automation

  • Headquarters: Philadelphia , Pennsylvania

  • Year Founded: 2021

  • Traction: Seven figure revenue with thousands of daily authorizations and large scale automation in production

Founder Profiles

  • Daniel Friedman, Co-Founder, CEO: Former founder of Backtrace and Vidoni AR with experience in enterprise product and sales.

  • Mical Such, Co-Founder, Chief Engineer: AI and DevOps leader with over a decade of experience building enterprise systems.

  • John Cococcia, CFO: Co-founded a $100M fund and led strategy and partnerships at Plug Power.

Funding

Revenue Engine

  • Enterprise SaaS: Annual licenses ranging from $200K to $500K for providers and payors.

  • Transaction Fees: $3 to $15 per automated prior authorization processed.

  • Integration Fees: One time onboarding fees between $50K and $250K tied to system integration.

What Users Love

  • Works inside existing EHR and utilization management tools with no new portals or retraining.

  • Automates the end to end workflow including clinical review and rationale for each case.

  • Enriches every authorization with audit ready documentation and a roadmap for non automated cases.

  • Reduces labor burden through compounding accuracy and payor aligned presentation.

Playing Field

  • Epic, Optum, Waystar: Offer workflow tools but require heavy implementation and operational changes.

  • Cohere Health and XSOLIS: Provide partial automation but still depend on human decision layers.

  • Humata Health: Moves closer to automation but does not deliver full end to end execution.

EtherMed’s Edge: Fully automated system embedded in existing workflows that minimizes change management while improving over time.

Why It Matters

The $80B+ labor burden of prior authorization stems from a fragmented paper era process that no modern tool has replaced. As health systems face staffing pressure and regulators increase scrutiny on denial practices, demand for automation within existing infrastructure is large and immediate.

What Sets Them Apart

  • Backend Integration: Runs entirely within existing systems, avoiding new interfaces or user training.

  • Learning System: Continuously improves accuracy using historical data and real time feedback loops.

  • Standards Support: Compatible with FHIR, HL7, and X12, enabling broad interoperability.

  • Proven Scale: Processes millions of transactions and thousands of daily authorizations in production.

  • Clear ROI: Demonstrated labor savings and faster turnaround times for enterprise customers.

Analysis

Bulls Case 📈 

  • Large addressable market with clear $80B labor burden and $21B TAM based on transaction economics.

  • Flagship customer results demonstrate 85% automation and 18 FTEs saved, creating strong ROI for prospects.

  • Integration approach reduces change friction, potentially shortening sales cycles.

  • Network architecture allows expansion across service lines without new technical work.

Bears Case 📉 

  • Healthcare sales cycles are long, and scaling from 1 to 10+ enterprise customers requires repeatability.

  • Large incumbents with existing relationships may expand automation capabilities.

  • Healthcare workflows are tightly regulated and subject to policy changes.

  • Must maintain automation accuracy across thousands of plans and hundreds of rules per plan.

Verdict

EtherMed targets a costly bottleneck with built in urgency and budget. Its edge is embedding into existing workflows, reducing adoption friction and creating a path to become a system of record with data and network effects across providers and payors.

The risk is remaining a point solution. Integration depth, speed, and proof at large systems will determine expansion. If execution holds, EtherMed can become the default transaction layer for prior authorization.

Want To Evaluate A Startup Like An Investor?

We built a simple evaluation tool to help founders and emerging angels assess startup strength in few seconds.

Try it here. It’s completely Free!

The Startup Pulse

Another happening week in startup funding. Three signals from this week:

  1. AI developer platforms continue attracting large late stage capital

  2. Robotics and autonomous systems are seeing renewed investor interest

  3. Specialized AI tools for enterprise workflows are gaining traction

  • Replit — Secured $400M Series D at a ~$9B valuation to expand its AI native coding platform and developer ecosystem.

  • Sunday — Closed a $165M Series B to scale its autonomous lawn care robots and expand into residential markets.

  • Juicebox — Announced an $80M Series B at an ~$850M valuation to build AI driven recruiting infrastructure focused on earlier candidate engagement.

Written by Ashher

Update your email preferences or unsubscribe here

© 2025 AngelsRound

228 Park Ave S, #29976, New York, New York 10003, United States